Print Send My Information

Purpose

This study will determine if airway resistance to airflow and pressure, measured by Oscillometry, is associated with abnormal findings on Cardiopulmonary Exercise Testing in subjects who are experiencing shortness of breath.

Conditions

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Willingness to perform breathing test - Must be able to speak and understand English - Referred for Cardiopulmonary Exercise Testing

Exclusion Criteria

  • Unable to provide consent or perform oscillometry test

Study Design

Phase
Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
Subjects with dyspnea referred for Cardiopulmonary Exercise Testing Subjects with unexplained dyspnea referred for Cardiopulmonary Exercise Testing.
  • Device: Oscillometer
    The tremoFlo C-100 Airwave Oscillometry System is intended to measure respiratory system impedance using the Forced Oscillation Technique (FOT).
    Other names:
    • THORASYS tremoFlo C-100 Airwave Oscillometry System

Recruiting Locations

Highland Hospital
Rochester, New York 14620
Contact:
PATRICK A DONOHUE, MD
5853416774
patrick_donohue@urmc.rochester.edu

More Details

NCT ID
NCT06554353
Status
Recruiting
Sponsor
University of Rochester

Study Contact

PATRICK DONOHUE, MD
716-226-8429
patrick_donohue@urmc.rochester.edu

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.

For help using this page: trialstoday@researchmatch.org or call 855-514-7001

ResearchMatch is funded in part by the National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program, led by the NIH’s National Center for Advancing Translational Sciences (NCATS), grants UL1TR000445 and 1U54RR032646-01, and grant U24TR001579 from NCATS and the National Library of Medicine. The content of this website is solely the responsibility of ResearchMatch and Vanderbilt University and does not necessarily represent the official views of the NIH, NCATS, or NLM.

Vanderbilt University Medical Center